Chronic Fatigue Syndrome News and Research

Latest Chronic Fatigue Syndrome News and Research

Chelsea Therapeutics announces new investigator to conduct phase II clinical study of Droxidopa

Chelsea Therapeutics announces new investigator to conduct phase II clinical study of Droxidopa

Deconstruction of biomedical research on pain will improve diagnosis, treatment of chronic pain sufferers

Deconstruction of biomedical research on pain will improve diagnosis, treatment of chronic pain sufferers

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

Investment report on Hemispherx BioPharma

Investment report on Hemispherx BioPharma

AIDS specialist leaves Calif. practice, citing rising costs

AIDS specialist leaves Calif. practice, citing rising costs

CFIDS Association applauds AABB for responding to questions about safety of general blood supply

CFIDS Association applauds AABB for responding to questions about safety of general blood supply

Hemispherx announces exclusive revenue sharing agreement with GP Pharm

Hemispherx announces exclusive revenue sharing agreement with GP Pharm

Corvalen M introduced for treatment of fibromyalgia symptoms

Corvalen M introduced for treatment of fibromyalgia symptoms

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

WPI, Cerus announce positive results from study of INTERCEPT Blood System to inactivate XMRV

MicroStockProfit.com releases investment report featuring Hemispherx Biopharma

MicroStockProfit.com releases investment report featuring Hemispherx Biopharma

Hemispherx Biopharma reports net loss of $13,438,000 for fiscal year 2009

Hemispherx Biopharma reports net loss of $13,438,000 for fiscal year 2009

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

XMRV infection is not linked to chronic fatigue syndrome

XMRV infection is not linked to chronic fatigue syndrome

CFIDS Association of America issues statement in response to XMRV study

CFIDS Association of America issues statement in response to XMRV study

Findings suggest abuse is a risk factor for chronic headache

Findings suggest abuse is a risk factor for chronic headache

A properly managed metabolic detoxification program can benefit

A properly managed metabolic detoxification program can benefit

Hypothalamic dysfunction can cause Chronic Fatigue Syndrome

Hypothalamic dysfunction can cause Chronic Fatigue Syndrome

Innovative treatments for bowel dysfunction

Innovative treatments for bowel dysfunction

Department of Veterans Affairs cancels contract with UTSWMC for Gulf War research

Department of Veterans Affairs cancels contract with UTSWMC for Gulf War research

Funding boost for research into chronic fatigue syndrome in children

Funding boost for research into chronic fatigue syndrome in children